Skip to content

Phone-alt Phone-alt Envelope Map-marker-alt Map-marker-alt

Search

Close

Home
About us
- Investment strategy
- Investment focus
Investments
- rancoderm GmbH
Investor Relations
News
- Corporate News
- ad-hoc notification
Contact

Menu

Home
About us
- Investment strategy
- Investment focus
Investments
- rancoderm GmbH
Investor Relations
News
- Corporate News
- ad-hoc notification
Contact

Research

First Berlin Research 31-07-2023

Contact

Vorstand:
Andreas Danner
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany

T. +49 6221 64924 88
kontakt(@)bioxxmed.ag

About us

Investment strategy
Investment focus

Menu

Investment strategy
Investment focus

Investments

rancoderm GmbH

Menu

rancoderm GmbH

Investor Relations

Shares
Annual Reports
Annual Accounts
Annual Shareholders’ Meeting
Directors' Dealings
Management
Investors’ Relations Contact
Reports
Kapitalerhöhung 2024

Menu

Shares
Annual Reports
Annual Accounts
Annual Shareholders’ Meeting
Directors' Dealings
Management
Investors’ Relations Contact
Reports
Kapitalerhöhung 2024

News

Corporate News
ad-hoc notification

Menu

Corporate News
ad-hoc notification

© 2025 All Rights Reserved by bioXXmed Ag

Disclaimer
Data Privacy
Legal information

Menu

Disclaimer
Data Privacy
Legal information

EN

+49 6221 6492488

Vorstand: Andreas Danner
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany

I allow my details from the contact form to be collected and processed in order to answer my inquiry. The data will be deleted after the processing of your request has been completed.
Note: You can revoke your consent at any time for the future by sending an e-mail to. Detailed information on the handling of user data can be found in our privacy policy.

+49 6221 6492488

kontakt@bioxxmed.ag

Vorstand: Andreas Danner
Ziegelhäuser Landstraße 3
69120 Heidelberg
Germany